Market Place
Sourcing Support
LinKinVax & Gustave Announced First Patient Dosed in Ph I/IIa Study on HPV.DCVax
18 Sep 2023 //
BUSINESSWIRE
LinkinVAX Completes First Batch Production of “PanCov”
20 Jul 2023 //
BUSINESSWIRE
LinKinVax Introduces its Scientific Advisory Board with the Appointment
26 Apr 2023 //
BUSINESSWIRE
LinKinVax Welcomes Results of ANRS VRI06 PI Evaluating HIV Vaccine Candidate
22 Feb 2023 //
BUSINESSWIRE
LinKinVax & Gustave Collaborate on Ph I/IIa HPV.DCVax Trial
19 Jan 2023 //
BUSINESSWIRE
LinKinVax Just Completed a New Round of Financing, Initiated in 2022
09 Jan 2023 //
BUSINESSWIRE
LinKinVax to Lead the Clinical Development and Upscaling of Its Vaccine Platform
19 May 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.